NEW YORK (GenomeWeb) – Enzo Life Sciences has entered into a settlement and license agreement with Hologic, Grifols, and Grifols Diagnostic Solutions, Enzo disclosed in a recent filing with the US Securities and Exchange Commission.
The agreement settles all outstanding patent disputes among the parties and includes a one-time payment of $14 million to Enzo in exchange for fully paid-up, worldwide licenses to Hologic and Grifols, according to the SEC document.